B. Riley Starts CTS Corp (CTS) at Buy
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
B. Riley initiated coverage on CTS Corp (NYSE: CTS) with a Buy rating and a price target of $22.00.
Shares of CTS Corp closed at $18.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CTS Corporation Announces Dates for Fourth Quarter and Full Year 2016 Earnings Release and Conference Call
- UPDATE: Ladenburg Thalmann Starts TC Pipelines (TCP) at Neutral
- UPDATE: Benchmark Starts Cross Country Healthcare (CCRN) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesB. Riley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!